Patents by Inventor Ariel Mittelman

Ariel Mittelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230382914
    Abstract: Disclosed are solid state forms of lumateperone ditosylate, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 14, 2023
    Publication date: November 30, 2023
    Inventors: Ariel MITTELMAN, Ido FUCHS, Sharona SHACHANTOV, Doron RUDIK, Rotem SELLA-EREZ
  • Patent number: 11760757
    Abstract: Disclosed are solid state forms of lumateperone ditosylate, uses thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: September 19, 2023
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Ariel Mittelman, Ido Fuchs, Sharona Shachantov, Doron Rudik, Rotem Sella-Erez
  • Patent number: 11332469
    Abstract: Disclosed are solid state forms of lumateperone ditosylate, uses thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: May 17, 2022
    Assignee: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
    Inventors: Ariel Mittelman, Ido Fuchs, Sharona Shachantov, Doron Rudik, Rotem Sella-Erez
  • Publication number: 20220127259
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Publication number: 20220127268
    Abstract: Disclosed are solid state forms of lumateperone ditosylate, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 7, 2022
    Publication date: April 28, 2022
    Inventors: Ariel MITTELMAN, Ido FUCHS, Sharona SHACHANTOV, Doron RUDIK, Rotem SELLA-EREZ
  • Patent number: 11242341
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: February 8, 2022
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Patent number: 10584100
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: September 4, 2019
    Date of Patent: March 10, 2020
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • Publication number: 20200048244
    Abstract: Solid state forms of Valbenazine, Valbenazine salts, processes for preparation thereof and pharmaceutical compositions thereof are disclosed. Processes for the preparation of Valbenazine and intermediates in the preparation thereof are further described.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 13, 2020
    Inventors: Ariel Mittelman, Sharona Shachan-Tov, Abed Masarwa, Rotem Sella-Erez, Jonathan Enav, Motti Erlich, Victoria Machtey, Maytal Piran, Marina Yarovoy, Sagit Azran, Einat Kisin-Finfer, Tamar Nidam
  • Publication number: 20190389807
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 4, 2019
    Publication date: December 26, 2019
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • Patent number: 10442770
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: February 1, 2018
    Date of Patent: October 15, 2019
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • Publication number: 20190211015
    Abstract: Disclosed are solid state forms of lumateperone ditosylate, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 8, 2017
    Publication date: July 11, 2019
    Inventors: Ariel MITTELMAN, Ido FUCHS, Sharona SHACHANTOV, Doron RUDIK, Rotem SELLA-EREZ
  • Publication number: 20180273499
    Abstract: The present disclosure relates to new salts of Vortioxetine, including butyrate, iso-butyrate, benzoate and propionate, solid state forms of the Vortioxetine salts, processes for the preparation thereof, pharmaceutical formulations/compositions thereof, and methods of use thereof.
    Type: Application
    Filed: March 19, 2018
    Publication date: September 27, 2018
    Applicant: Teva Pharmaceuticals International GmbH
    Inventors: Sharona SHACHANTOV, Doron RUDIK, Ariel MITTELMAN, Rotem SELLA-EREZ, Yuval COHEN, Jonathan ENAV, Vera KESELMAN, Gustavo FRENKEL, Moshe BAR, Polina LAPIDO
  • Publication number: 20180215715
    Abstract: Disclosed are solid state forms of Netarsudil mesylate, processes for preparation thereof, uses thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: February 1, 2018
    Publication date: August 2, 2018
    Inventors: Alexander Mainfeld, Sharona Shachan-tov, Ariel Mittelman, Rotem Sella-Erez, Yifat Ronen, Tamar Nidam
  • Patent number: 10035802
    Abstract: The present invention encompasses solid state forms of Ibrutinib, including forms G, J and K, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: July 31, 2018
    Assignee: TEVA PHARMACEUTICALS USA, INC.
    Inventors: Meital Cohen, Yuval Cohen, Ariel Mittelman, Elana Ben Moha-Lerman, Idit Tzanani, Leonid Levenfeld
  • Publication number: 20170226114
    Abstract: The present invention encompasses solid state forms of Ibrutinib, including forms G, J and K, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 13, 2015
    Publication date: August 10, 2017
    Inventors: Meital Cohen, Yuval Cohen, Ariel Mittelman, Elana Ben Moha-Lerman, Idit Tzanani, Leonid Levenfeld
  • Publication number: 20160200716
    Abstract: The present invention encompasses Cobicistat dihydrochloride salt, and pharmaceutical compositions thereof.
    Type: Application
    Filed: December 23, 2013
    Publication date: July 14, 2016
    Applicant: Assia Chemical Industries Ltd.
    Inventors: Jacob RENDELL, Ariel MITTELMAN, Sofia GOROHOVSKY, Motti ERLICH
  • Publication number: 20120316175
    Abstract: Solid state forms of Sitagliptin salts, processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided.
    Type: Application
    Filed: August 20, 2012
    Publication date: December 13, 2012
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Gideon PILARSKI, Nurit PERLMAN, Ariel MITTELMAN, Nada KOSUTIC HULITA, Marina KALUJNY, Revital RAMATY
  • Patent number: 8329696
    Abstract: Solid state forms of Sitagliptin salts (e.g. Sitagliptin sulfate, Formula I), processes for preparing the solid state forms, and pharmaceutical compositions thereof, are provided. These compounds are of a class of dipeptidyl peptidase IV enzyme inhibitors which are useful, for example, for the manufacture of a medicament for the treatment of type 2 diabetes mellitus.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: December 11, 2012
    Assignee: Teva Pharmaceuticals Industries Ltd.
    Inventors: Gideon Pilarski, Nurit Perlman, Ariel Mittelman, Nada Kosutic Hulita, Marina Kalujny, Revital Ramaty
  • Publication number: 20120289701
    Abstract: The present invention provides novel polymorphs of lapatinib ditosylate, processes for preparing them, and pharmaceutical compositions comprising one or more of these polymorphs.
    Type: Application
    Filed: July 24, 2012
    Publication date: November 15, 2012
    Inventors: Leonid METSGER, Ariel MITTELMAN, Slavik YURKOVSKI
  • Publication number: 20120220663
    Abstract: The present invention provides polymorphic forms of aliskiren hemifumarate, and processes for preparation thereof and for the preparation of the amorphous form of aliskiren hemifumarate. The present invention also provides pharmaceutical compositions comprising the aliskiren hemifumarate crystalline forms T1, T3 or T4, T5, T6, T7, T8 and at least one pharmaceutically acceptable excipient, and the use of these pharmaceutical compositions in the treatment of hypertension.
    Type: Application
    Filed: September 2, 2010
    Publication date: August 30, 2012
    Applicants: TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Marina Etinger, Rinat Moshkovits Kaptsan, Ariel Mittelman